Search

Search Constraints

You searched for: Author/Creator Yorsaeng, Ritthideach

Search Results

1. Breakthrough Infection by SARS-CoV-2 Delta and Omicron Variants Elicited Immune Response Comparable to mRNA Booster Vaccination . (5th July 2022)

2. Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine. Issue 39 (16th September 2022)

3. Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults. Issue 3 (24th January 2022)

4. Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study. (October 2022)

5. Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data. Issue 23 (20th May 2022)

6. Immunogenicity of the BNT162b2 COVID-19 vaccine as a third dose (booster) following two doses of different primary series regimens in Thailand. (3rd October 2022)

7. Impact of COVID-19 public health interventions on influenza incidence in Thailand. (3rd July 2020)

8. Impact of COVID-19 public health interventions on influenza incidence in Thailand. (3rd July 2020)

9. Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination . (10th March 2022)

10. Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens. (January 2023)